Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
3.00 Up 0.01(0.33%) 4:00PM EDT
Add to Portfolio
Prev Close:2.99
Open:2.98
Bid:N/A
Ask:3.11 x 500
1y Target Est:10.00
Beta:2.23944
Next Earnings Date:N/A
Day's Range:2.92 - 3.10
52wk Range:1.56 - 5.20
Volume:395,640
Avg Vol (3m):508,909
Market Cap:265.51M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGLUp 0.33%265.51M
AMGNDown 2.64%115.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.71
Quarterly EPS Est (Sep-15) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback